Researchers at Columbia University's Mailman School of Public Health, working with colleagues at the Vagelos College of Physicians and Surgeons, the Columbia School of Nursing, the University of Miami and the University of Chicago, have assembled one of the largest clinical datasets ever built for dementia research. Described in the journal Alzheimer's & Dementia, the M3AD Study and Real-World Data Metaplatform pulls together and harmonizes electronic health records from nearly 10 million patients across three major health systems in New York City, Chicago and Miami, including roughly 60,000 people diagnosed with Alzheimer's disease or a related dementia.
What sets the platform apart is not just its size but how it handles complexity. Most dementia research examines one condition at a time. This platform tracks multiple chronic diseases, behaviors and social conditions at once and follows how they interact across years, which the researchers say should improve predictions of both who develops dementia and how their disease progresses.
That design reflects a practical reality of aging: chronic illnesses rarely arrive alone. Diabetes, cardiovascular disease, depression and other conditions accumulate and influence one another, producing health trajectories that disease-by-disease studies struggle to represent. For clinicians and families, better modeling of those combined patterns could eventually mean earlier and more accurate identification of who is at highest risk, and clearer targets for prevention.
Because the data come from real-world clinical care rather than a controlled trial population, the platform captures patients as they actually present to health systems in three demographically distinct cities. The team frames the effort as infrastructure for precision aging research - a resource meant to speed up discovery rather than a single finding in itself.